GRI Bio Statistics

Total Valuation

GRI Bio has a market cap or net worth of $4.01 million. The enterprise value is -$600,249.

Market Cap	4.01M
Enterprise Value	-600,249

Important Dates

The next estimated earnings date is Thursday, March 27, 2025, before market open.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

GRI Bio has 525,491 shares outstanding.

Current Share Class	525,491
Shares Outstanding	525,491
Shares Change (YoY)	n/a
Shares Change (QoQ)	+590.51%
Owned by Insiders (%)	0.09%
Owned by Institutions (%)	2.51%
Float	524,886

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.62
P/TBV Ratio	1.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.10, with a Debt / Equity ratio of 0.04.

Current Ratio	3.10
Quick Ratio	2.77
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -280.72% and return on invested capital (ROIC) is -171.75%.

Return on Equity (ROE)	-280.72%
Return on Assets (ROA)	-105.28%
Return on Invested Capital (ROIC)	-171.75%
Return on Capital Employed (ROCE)	-221.88%
Revenue Per Employee	n/a
Profits Per Employee	-$2.07M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.78% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-95.78%
50-Day Moving Average	10.91
200-Day Moving Average	20.91
Relative Strength Index (RSI)	36.94
Average Volume (20 Days)	14,745

Short Selling Information

The latest short interest is 404,302, so 76.94% of the outstanding shares have been sold short.

Short Interest	404,302
Short Previous Month	348,603
Short % of Shares Out	76.94%
Short % of Float	77.03%
Short Ratio (days to cover)	2.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.31M
Pretax Income	-12.77M
Net Income	-8.26M
EBITDA	-8.30M
EBIT	-8.31M
Earnings Per Share (EPS)	-$134.26

Full Income Statement

Balance Sheet

The company has $4.75 million in cash and $131,000 in debt, giving a net cash position of $4.62 million or $8.78 per share.

Cash & Cash Equivalents	4.75M
Total Debt	131,000
Net Cash	4.62M
Net Cash Per Share	$8.78
Equity (Book Value)	3.66M
Book Value Per Share	12.39
Working Capital	3.61M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-12.17M
Capital Expenditures	n/a
Free Cash Flow	-12.17M
FCF Per Share	-$23.16

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRI Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-205.82%
FCF Yield	-303.18%

Analyst Forecast

The average price target for GRI Bio is $11.50, which is 50.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.50
Price Target Difference	50.52%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 24, 2025. It was a reverse split with a ratio of 0.0588235:1.

Last Split Date	Feb 24, 2025
Split Type	Reverse
Split Ratio	0.0588235:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1